M24-885: A Phase 2a Multicenter, Randomized, Platform Study of Targeted Therapies for the Treatment of Adult Subjects with Moderate to Severe Crohn's Disease

Grants and Contracts Details

StatusActive
Effective start/end date11/11/2411/11/27

Funding

  • AbbVie Incorporated: $2.00